These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7015481)

  • 1. Human membrane-bound C3 receptors. II. Physiochemical properties of the C3b and C3d receptors isolated from tonsil cells by immunoprecipitation.
    Gerdes J; Stein H
    Scand J Immunol; 1981; 13(1):77-86. PubMed ID: 7015481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation.
    Gerdes J; Stein H
    Immunology; 1980 Dec; 41(4):929-36. PubMed ID: 7461716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
    Gerdes J; Naiem M; Mason DY; Stein H
    Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistological demonstration and physiochemical characterization of C3 receptors of normal and neoplastic lymphoid cells.
    Gerdes J; Stein H
    J Cancer Res Clin Oncol; 1981; 101(1):69-74. PubMed ID: 7024285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human membrane-bound C3 receptors. I. Serological and immunohistological demonstration of C3 receptors.
    Stein H; Gerdes J; Tolksdorf G; Klatt U
    Scand J Immunol; 1981; 13(1):67-76. PubMed ID: 7015480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisera with anti-pan C3 receptor reactivity which block complement C3b, C3bi and C3d receptors.
    Gerdes J; Stein H; Dierich MP; Conrad DH
    J Immunol Methods; 1982 Jun; 51(2):259-65. PubMed ID: 7050249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
    Freedman J; Massey A
    J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.
    Cole JL; Housley GA; Dykman TR; MacDermott RP; Atkinson JP
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):859-63. PubMed ID: 3871945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.